U
Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
D
Sell
2/22/2018Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to D from D- on 2/22/2018 due to an increase in the total return index, volatility index and valuation index.
Entia Biosciences, Inc (ERGO) was upgraded to D from D- on 2/22/2018 due to an increase in the total return index, volatility index and valuation index.
D
Sell
5/19/2017Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D- from D on 5/19/2017 due to a decline in the growth index, solvency index and volatility index. Operating cash flow declined 497.83% from -$73.6 to -$440, earnings per share declined from -$0.0103 to -$0.0158, and EBIT declined 23.69% from -$271.4 to -$335.7.
Entia Biosciences, Inc (ERGO) was downgraded to D- from D on 5/19/2017 due to a decline in the growth index, solvency index and volatility index. Operating cash flow declined 497.83% from -$73.6 to -$440, earnings per share declined from -$0.0103 to -$0.0158, and EBIT declined 23.69% from -$271.4 to -$335.7.
D
Sell
9/30/2016Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to D from D- on 9/30/2016 due to a noticeable increase in the growth index. Total revenue increased 24.24% from $79.2 to $98.4.
Entia Biosciences, Inc (ERGO) was upgraded to D from D- on 9/30/2016 due to a noticeable increase in the growth index. Total revenue increased 24.24% from $79.2 to $98.4.
D
Sell
5/18/2016Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D- from D on 5/18/2016 due to a large decline in the growth index, solvency index and total return index. The quick ratio declined from 0.03 to 0.01, operating cash flow declined 67% from -$59.4 to -$99.2, and EBIT declined 57.84% from -$171 to -$269.9.
Entia Biosciences, Inc (ERGO) was downgraded to D- from D on 5/18/2016 due to a large decline in the growth index, solvency index and total return index. The quick ratio declined from 0.03 to 0.01, operating cash flow declined 67% from -$59.4 to -$99.2, and EBIT declined 57.84% from -$171 to -$269.9.
D
Sell
3/11/2016Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
Entia Biosciences, Inc (ERGO) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
1/15/2016Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C- on 1/15/2016 due to a noticeable decline in the total return index.
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C- on 1/15/2016 due to a noticeable decline in the total return index.
C
Hold
12/31/2015Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index, efficiency index and total return index.
Entia Biosciences, Inc (ERGO) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index, efficiency index and total return index.
D
Sell
11/14/2014Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C on 11/14/2014 due to a significant decline in the efficiency index and growth index. Total capital declined 115.65% from -$711.8 to $111.4, EBIT declined 25.24% from -$517.1 to -$386.6, and total revenue declined 16.14% from $104.7 to $87.8.
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C on 11/14/2014 due to a significant decline in the efficiency index and growth index. Total capital declined 115.65% from -$711.8 to $111.4, EBIT declined 25.24% from -$517.1 to -$386.6, and total revenue declined 16.14% from $104.7 to $87.8.
C
Hold
10/30/2014Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to C from C- on 10/30/2014 due to an increase in the total return index.
Entia Biosciences, Inc (ERGO) was upgraded to C from C- on 10/30/2014 due to an increase in the total return index.
C
Hold
9/2/2014Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to C- from C on 9/2/2014 due to a decline in the total return index.
Entia Biosciences, Inc (ERGO) was downgraded to C- from C on 9/2/2014 due to a decline in the total return index.
C
Hold
8/15/2014Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to C from C- on 8/15/2014 due to an increase in the growth index. Operating cash flow increased 80.7% from -$91.7 to -$165.7, and EBIT increased 16.28% from -$444.7 to -$517.1.
Entia Biosciences, Inc (ERGO) was upgraded to C from C- on 8/15/2014 due to an increase in the growth index. Operating cash flow increased 80.7% from -$91.7 to -$165.7, and EBIT increased 16.28% from -$444.7 to -$517.1.
C
Hold
8/5/2014Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to C- from C on 8/5/2014 due to a significant decline in the volatility index and total return index.
Entia Biosciences, Inc (ERGO) was downgraded to C- from C on 8/5/2014 due to a significant decline in the volatility index and total return index.
C
Hold
5/16/2014Upgraded
Entia Biosciences, Inc (ERGO) was upgraded to C from D+ on 5/16/2014 due to a significant increase in the efficiency index, growth index and total return index. Total revenue increased 209.71% from $52.5 to $162.6, and total capital increased 39.33% from -$526.6 to -$733.7.
Entia Biosciences, Inc (ERGO) was upgraded to C from D+ on 5/16/2014 due to a significant increase in the efficiency index, growth index and total return index. Total revenue increased 209.71% from $52.5 to $162.6, and total capital increased 39.33% from -$526.6 to -$733.7.
D
Sell
4/2/2014Downgrade
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C on 4/2/2014 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.1 to 0.03, and total revenue declined 43% from $92.1 to $52.5.
Entia Biosciences, Inc (ERGO) was downgraded to D+ from C on 4/2/2014 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.1 to 0.03, and total revenue declined 43% from $92.1 to $52.5.
OTC PK
01/13/2025 12:35PM Eastern
Quotes delayed
